Lexaria Bioscience Corp. (LEXXW) Stock Analysis

What Lexaria Bioscience Corp. does

Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

Key metrics

ETFs linked to LEXXW

Broad-market and Healthcare sector ETFs an investor holding Lexaria Bioscience Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LEXXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Lexaria Bioscience Corp.?

Lexaria Bioscience Corp. trades under the ticker LEXXW on NASDAQ.

Which exchange is LEXXW listed on?

LEXXW is listed on NASDAQ.

What sector does Lexaria Bioscience Corp. operate in?

Lexaria Bioscience Corp. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LEXXW in a portfolio?

PortView shows LEXXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.